A de novo deletion in a boy with cerebral palsy suggests a refined critical region for the 4q21.22 microdeletion syndrome
- PMID: 28371330
- DOI: 10.1002/ajmg.a.38176
A de novo deletion in a boy with cerebral palsy suggests a refined critical region for the 4q21.22 microdeletion syndrome
Abstract
We present an 18-year-old boy with cerebral palsy, intellectual disability, speech delay, and seizures. He carries a likely pathogenic 1.3 Mb de novo heterozygous deletion in the 4q21.22 microdeletion syndrome region. He also carries a 436 kb maternally-inherited duplication impacting the first three exons of CHRNA7. The majority of previously published cases with 4q21.22 syndrome shared common features including growth restriction, muscular hypotonia, and absent or severely delayed speech. Using copy number variation (CNV) data available for other subjects, we defined a minimal critical region of 170.8 kb within the syndromic region, encompassing HNRNPD. We also identified a larger 2 Mb critical region encompassing ten protein-coding genes, of which six (PRKG2, RASGEF1B, HNRNPDL, HNRNPD, LIN54, COPS4) have a significantly low number of truncating loss-of-function mutations. Long-range chromatin interaction data suggest that this deletion may alter chromatin interactions at the 4q21.22 microdeletion region. We suggest that the deletion or misregulation of these genes is likely to contribute to the neurodevelopmental and neuromuscular abnormalities in 4q21.22 syndrome.
Keywords: intellectual disability; 4q21.22 microdeletion syndrome; HNRNPD; cerebral palsy; copy number variation; delayed speech.
© 2017 Wiley Periodicals, Inc.
Similar articles
-
Microdeletion at chromosome 4q21 defines a new emerging syndrome with marked growth restriction, mental retardation and absent or severely delayed speech.J Med Genet. 2010 Jun;47(6):377-84. doi: 10.1136/jmg.2009.071902. J Med Genet. 2010. PMID: 20522426
-
Further defining the critical genes for the 4q21 microdeletion disorder.Am J Med Genet A. 2017 Jan;173(1):120-125. doi: 10.1002/ajmg.a.37965. Epub 2016 Sep 8. Am J Med Genet A. 2017. PMID: 27604828
-
A de novo microtriplication at 4q21.21-q21.22 in a patient with a vascular malignant hemangioma, elongated sigmoid colon, developmental delay, and absence of speech.Am J Med Genet A. 2016 Aug;170(8):2089-96. doi: 10.1002/ajmg.a.37754. Epub 2016 Jun 10. Am J Med Genet A. 2016. PMID: 27288323
-
8.6Mb interstitial deletion of chromosome 4q13.3q21.23 in a boy with cognitive impairment, short stature, hearing loss, skeletal abnormalities and facial dysmorphism.Genet Couns. 2011;22(4):353-63. Genet Couns. 2011. PMID: 22303795 Review.
-
Compound heterozygous microdeletion of chromosome 15q13.3 region in a child with hypotonia, impaired vision, and global developmental delay.Am J Med Genet A. 2014 Jul;164A(7):1815-20. doi: 10.1002/ajmg.a.36535. Epub 2014 Apr 3. Am J Med Genet A. 2014. PMID: 24700535 Review.
Cited by
-
Etiology of intellectual disability in individuals from special education schools in the south of Brazil.BMC Pediatr. 2020 Nov 4;20(1):506. doi: 10.1186/s12887-020-02382-5. BMC Pediatr. 2020. PMID: 33143672 Free PMC article.
-
De novo and rare inherited copy-number variations in the hemiplegic form of cerebral palsy.Genet Med. 2018 Feb;20(2):172-180. doi: 10.1038/gim.2017.83. Epub 2017 Aug 3. Genet Med. 2018. PMID: 28771244 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
